1227177-68-5 Usage
Description
3-cyclopropyl-2-fluoropyridine is a chemical compound characterized by the presence of a cyclopropyl ring and a fluorine-substituted pyridine ring. This molecule is distinguished by the stability imparted by the cyclopropyl group and the enhanced lipophilicity and biological activity due to the fluorine atom substitution. It is a versatile intermediate in the synthesis of various pharmaceuticals and agrochemicals, known for its unique reactivity and physical properties.
Uses
Used in Pharmaceutical Industry:
3-cyclopropyl-2-fluoropyridine is used as a key intermediate in the synthesis of pharmaceuticals for its potential to contribute to the development of new drugs. The cyclopropyl group and fluorine substitution can influence the pharmacokinetics and pharmacodynamics of the resulting compounds, potentially leading to improved therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, 3-cyclopropyl-2-fluoropyridine is utilized as a precursor in the production of herbicides and insecticides. Its chemical structure allows for the creation of compounds that can effectively control pests and weeds, thereby enhancing crop protection and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 1227177-68-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,7,1,7 and 7 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1227177-68:
(9*1)+(8*2)+(7*2)+(6*7)+(5*1)+(4*7)+(3*7)+(2*6)+(1*8)=155
155 % 10 = 5
So 1227177-68-5 is a valid CAS Registry Number.
1227177-68-5Relevant articles and documents
NEW SOMATOSTATIN RECEPTOR SUBTYPE 4 (SSTR4) AGONISTS
-
Page/Page column 107; 108, (2014/12/12)
The invention relates to 3-aza-bicyclo[3.1.0]hexane-6-carboxylic acid amide derivatives of general formula (I), which are agonists of somatostatin receptor subtype 4 (SSTR4), useful for preventing or treating medical disorders related to SSTR4. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture of the compounds according to the invention.
